Lv2
148 积分 2022-08-19 加入
Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point
1天前
求助中
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection
1天前
已完结
Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer
11天前
已关闭
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
28天前
已完结
The US biosimilars market after one decade
29天前
已关闭
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
1个月前
已完结
Textbook of Cell Signalling in Cancer An Educational Approach
1个月前
已关闭
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types
1个月前
已关闭
Hallmarks of artificial intelligence contributions to precision oncology
1个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
1个月前
已完结
皖公网安备34019202002308
